Ablation Index and VISITAG (ABI-173)

· Biosense Webster, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ablation Index and VISITAG (ABI-173), covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Ablation Index and VISITAG™ (ABI-173) [NA]